Forskning ved Københavns Universitet - Københavns Universitet

Forside

Vitamin D-binding protein controls T cell responses to vitamin D

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Vitamin D-binding protein controls T cell responses to vitamin D. / Kongsbak, Martin; von Essen, Marina Rode; Levring, Trine Bøegh; Schjerling, Peter; Woetmann, Anders; Ødum, Niels; Bonefeld, Charlotte Menné; Geisler, Carsten.

I: B M C Immunology, Bind 15, 35, 2014, s. 1-13.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kongsbak, M, von Essen, MR, Levring, TB, Schjerling, P, Woetmann, A, Ødum, N, Bonefeld, CM & Geisler, C 2014, 'Vitamin D-binding protein controls T cell responses to vitamin D', B M C Immunology, bind 15, 35, s. 1-13. https://doi.org/10.1186/s12865-014-0035-2

APA

Kongsbak, M., von Essen, M. R., Levring, T. B., Schjerling, P., Woetmann, A., Ødum, N., ... Geisler, C. (2014). Vitamin D-binding protein controls T cell responses to vitamin D. B M C Immunology, 15, 1-13. [35]. https://doi.org/10.1186/s12865-014-0035-2

Vancouver

Kongsbak M, von Essen MR, Levring TB, Schjerling P, Woetmann A, Ødum N o.a. Vitamin D-binding protein controls T cell responses to vitamin D. B M C Immunology. 2014;15:1-13. 35. https://doi.org/10.1186/s12865-014-0035-2

Author

Kongsbak, Martin ; von Essen, Marina Rode ; Levring, Trine Bøegh ; Schjerling, Peter ; Woetmann, Anders ; Ødum, Niels ; Bonefeld, Charlotte Menné ; Geisler, Carsten. / Vitamin D-binding protein controls T cell responses to vitamin D. I: B M C Immunology. 2014 ; Bind 15. s. 1-13.

Bibtex

@article{155e52fff53a4ba09866ea609ba0ebd2,
title = "Vitamin D-binding protein controls T cell responses to vitamin D",
abstract = "BACKGROUND: In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation. However, the serum concentration of 1,25(OH)2D3 is far below the effective concentration of 1,25(OH)2D3 found in in vitro studies, and it has been suggested that 1,25(OH)2D3 must be produced locally from the inactive precursor 25-hydroxyvitamin D3 (25(OH)D3) to affect ongoing immune responses in vivo. Although it has been reported that activated T cells express the 25(OH)D-1α-hydroxylase CYP27B1 that converts 25(OH)D3 to 1,25(OH)2D3, it is still controversial whether activated T cells have the capacity to produce sufficient amounts of 1,25(OH)2D3 to affect vitamin D-responsive genes. Furthermore, it is not known how the vitamin D-binding protein (DBP) found in high concentrations in serum affects T cell responses to 25(OH)D3.RESULTS: We found that activated T cells express CYP27B1 and have the capacity to produce sufficient 1,25(OH)2D3 to affect vitamin D-responsive genes when cultured with physiological concentrations of 25(OH)D3 in serum-free medium. However, if the medium was supplemented with serum or purified DBP, DBP strictly inhibited the production of 1,25(OH)2D3 and 25(OH)D3-induced T cell responses. In contrast, DBP did not inhibit the effect of exogenous 1,25(OH)2D3. Actin, arachidonic acid and albumin did not affect the sequestration of 25(OH)D3 by DBP, whereas carbonylation of DBP did.CONCLUSIONS: Activated T cells express CYP27B1 and can convert 25(OH)D3 to 1,25(OH)2D3 in sufficiently high concentrations to affect vitamin D-responsive genes when cultured in serum-free medium. However, DBP sequesters 25(OH)D3 and inhibits the production of 1,25(OH)2D3 in T cells. To fully exploit the immune-regulatory potential of vitamin D, future studies of the mechanisms that enable the immune system to exploit 25(OH)D3 and convert it to 1,25(OH)2D3 in vivo are required.",
author = "Martin Kongsbak and {von Essen}, {Marina Rode} and Levring, {Trine B{\o}egh} and Peter Schjerling and Anders Woetmann and Niels {\O}dum and Bonefeld, {Charlotte Menn{\'e}} and Carsten Geisler",
year = "2014",
doi = "10.1186/s12865-014-0035-2",
language = "English",
volume = "15",
pages = "1--13",
journal = "B M C Immunology",
issn = "1471-2172",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Vitamin D-binding protein controls T cell responses to vitamin D

AU - Kongsbak, Martin

AU - von Essen, Marina Rode

AU - Levring, Trine Bøegh

AU - Schjerling, Peter

AU - Woetmann, Anders

AU - Ødum, Niels

AU - Bonefeld, Charlotte Menné

AU - Geisler, Carsten

PY - 2014

Y1 - 2014

N2 - BACKGROUND: In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation. However, the serum concentration of 1,25(OH)2D3 is far below the effective concentration of 1,25(OH)2D3 found in in vitro studies, and it has been suggested that 1,25(OH)2D3 must be produced locally from the inactive precursor 25-hydroxyvitamin D3 (25(OH)D3) to affect ongoing immune responses in vivo. Although it has been reported that activated T cells express the 25(OH)D-1α-hydroxylase CYP27B1 that converts 25(OH)D3 to 1,25(OH)2D3, it is still controversial whether activated T cells have the capacity to produce sufficient amounts of 1,25(OH)2D3 to affect vitamin D-responsive genes. Furthermore, it is not known how the vitamin D-binding protein (DBP) found in high concentrations in serum affects T cell responses to 25(OH)D3.RESULTS: We found that activated T cells express CYP27B1 and have the capacity to produce sufficient 1,25(OH)2D3 to affect vitamin D-responsive genes when cultured with physiological concentrations of 25(OH)D3 in serum-free medium. However, if the medium was supplemented with serum or purified DBP, DBP strictly inhibited the production of 1,25(OH)2D3 and 25(OH)D3-induced T cell responses. In contrast, DBP did not inhibit the effect of exogenous 1,25(OH)2D3. Actin, arachidonic acid and albumin did not affect the sequestration of 25(OH)D3 by DBP, whereas carbonylation of DBP did.CONCLUSIONS: Activated T cells express CYP27B1 and can convert 25(OH)D3 to 1,25(OH)2D3 in sufficiently high concentrations to affect vitamin D-responsive genes when cultured in serum-free medium. However, DBP sequesters 25(OH)D3 and inhibits the production of 1,25(OH)2D3 in T cells. To fully exploit the immune-regulatory potential of vitamin D, future studies of the mechanisms that enable the immune system to exploit 25(OH)D3 and convert it to 1,25(OH)2D3 in vivo are required.

AB - BACKGROUND: In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation. However, the serum concentration of 1,25(OH)2D3 is far below the effective concentration of 1,25(OH)2D3 found in in vitro studies, and it has been suggested that 1,25(OH)2D3 must be produced locally from the inactive precursor 25-hydroxyvitamin D3 (25(OH)D3) to affect ongoing immune responses in vivo. Although it has been reported that activated T cells express the 25(OH)D-1α-hydroxylase CYP27B1 that converts 25(OH)D3 to 1,25(OH)2D3, it is still controversial whether activated T cells have the capacity to produce sufficient amounts of 1,25(OH)2D3 to affect vitamin D-responsive genes. Furthermore, it is not known how the vitamin D-binding protein (DBP) found in high concentrations in serum affects T cell responses to 25(OH)D3.RESULTS: We found that activated T cells express CYP27B1 and have the capacity to produce sufficient 1,25(OH)2D3 to affect vitamin D-responsive genes when cultured with physiological concentrations of 25(OH)D3 in serum-free medium. However, if the medium was supplemented with serum or purified DBP, DBP strictly inhibited the production of 1,25(OH)2D3 and 25(OH)D3-induced T cell responses. In contrast, DBP did not inhibit the effect of exogenous 1,25(OH)2D3. Actin, arachidonic acid and albumin did not affect the sequestration of 25(OH)D3 by DBP, whereas carbonylation of DBP did.CONCLUSIONS: Activated T cells express CYP27B1 and can convert 25(OH)D3 to 1,25(OH)2D3 in sufficiently high concentrations to affect vitamin D-responsive genes when cultured in serum-free medium. However, DBP sequesters 25(OH)D3 and inhibits the production of 1,25(OH)2D3 in T cells. To fully exploit the immune-regulatory potential of vitamin D, future studies of the mechanisms that enable the immune system to exploit 25(OH)D3 and convert it to 1,25(OH)2D3 in vivo are required.

U2 - 10.1186/s12865-014-0035-2

DO - 10.1186/s12865-014-0035-2

M3 - Journal article

C2 - 25230725

VL - 15

SP - 1

EP - 13

JO - B M C Immunology

JF - B M C Immunology

SN - 1471-2172

M1 - 35

ER -

ID: 135491058